Filing Details

Accession Number:
0001610717-24-000347
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-20 16:10:50
Reporting Period:
2024-06-17
Accepted Time:
2024-06-20 16:10:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1628171 Revolution Medicines Inc. RVMD Biological Products, (No Disgnostic Substances) (2836) 472029180
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1872772 Lin Wei C/O Revolution Medicines, Inc.
700 Saginaw Drive
Redwood City CA 94063
Chief Medical Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-06-17 5,589 $37.39 70,851 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units ("RSUs") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes.
  2. This transaction was executed in multiple trades in prices ranging from $37.3867 to $37.3871, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  3. Includes 2,040 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2024.
  4. Includes 59,250 RSUs.